These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20078997)

  • 1. [Progresses in clinical application of rituximab in refractory nephrotic syndrome].
    Zhu BZ; Huang JP
    Zhonghua Er Ke Za Zhi; 2009 Nov; 47(11):845-7. PubMed ID: 20078997
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beneficial effects of rituximab in the treatment of refractory nephrotic syndrome].
    Imai E
    Nihon Jinzo Gakkai Shi; 2012; 54(5):593-7. PubMed ID: 22991838
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab for childhood-onset nephrotic syndrome.
    Hodson EM; Craig JC
    Lancet; 2014 Oct; 384(9950):1242-3. PubMed ID: 24965824
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rituximab for the treatment of nephrotic syndrome].
    Iijima K
    Nihon Jinzo Gakkai Shi; 2014; 56(4):471-7. PubMed ID: 24956878
    [No Abstract]   [Full Text] [Related]  

  • 5. Rituximab in steroid-dependent nephrotic syndrome.
    El Koumi M
    Iran J Kidney Dis; 2013 Nov; 7(6):502-6. PubMed ID: 24241100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Idiopathic nephrotic syndrome in children: from corticosteroids to rituximab].
    Deschênes G
    Arch Pediatr; 2011 Aug; 18(8):843-5. PubMed ID: 21719260
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
    Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
    Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term prognosis of patients with steroid-dependent nephrotic syndrome treated with rituximab].
    Kamei K; Okada M; Miyazono A; Sato M; Fujimaru T; Ogura M; Ito S
    Nihon Jinzo Gakkai Shi; 2013; 55(5):947-55. PubMed ID: 23980480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapies: Is there a role for rituximab in nephrotic syndrome?
    Feehally J
    Nat Rev Nephrol; 2014 May; 10(5):245-7. PubMed ID: 24614409
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab in steroid-resistant nephrotic syndrome in children: a (false) glimmer of hope?
    Pradhan M; Furth S
    J Am Soc Nephrol; 2012 Jun; 23(6):975-8. PubMed ID: 22581992
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.
    Kemper MJ; Gellermann J; Habbig S; Krmar RT; Dittrich K; Jungraithmayr T; Pape L; Patzer L; Billing H; Weber L; Pohl M; Rosenthal K; Rosahl A; Mueller-Wiefel DE; Dötsch J
    Nephrol Dial Transplant; 2012 May; 27(5):1910-5. PubMed ID: 22076431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for patients with nephrotic syndrome.
    Arnold DF; Misbah SA
    Lancet; 2015 Jan; 385(9964):226. PubMed ID: 25706702
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab for patients with nephrotic syndrome.
    Keijzer-Veen MG; Hebert D; Parekh RS;
    Lancet; 2015 Jan; 385(9964):225. PubMed ID: 25706701
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab for patients with nephrotic syndrome.
    Shin JI; Kronbichler A
    Lancet; 2015 Jan; 385(9964):225-6. PubMed ID: 25706700
    [No Abstract]   [Full Text] [Related]  

  • 15. Repeated course of rituximab for treatment of nephrotic syndrome in patients with chronic GVHD.
    Mellon-Reppen S; Ratanatharathorn V; Cronin S; Uberti JP
    Bone Marrow Transplant; 2010 Dec; 45(12):1758-9. PubMed ID: 20383208
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
    Kisner T; Burst V; Teschner S; Benzing T; Kurschat CE
    Nephron Clin Pract; 2012; 120(2):c79-85. PubMed ID: 22286071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for patients with nephrotic syndrome--authors' reply.
    Iijima K; Sako M; Nozu K; Nakamura H; Ito S
    Lancet; 2015 Jan; 385(9964):226-7. PubMed ID: 25706703
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab treatment for recurrence of nephrotic syndrome in a pediatric patient after renal transplantation for congenital nephrotic syndrome of Finnish type.
    Chaudhuri A; Kambham N; Sutherland S; Grimm P; Alexander S; Concepcion W; Sarwal M; Wong C
    Pediatr Transplant; 2012 Aug; 16(5):E183-7. PubMed ID: 21672106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab for steroid-dependent nephrotic syndrome.
    Beco A; Castro-Ferreira I; Coentrao L; Neto R; Sampaio S; Pestana M
    Clin Nephrol; 2010 Oct; 74(4):308-10. PubMed ID: 20875384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the role of rituximab in kidney diseases and transplant.
    Ramanath V; Nistala R; Chaudhary K
    Expert Opin Biol Ther; 2012 Feb; 12(2):223-33. PubMed ID: 22188359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.